Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ASCO GI 2024

Videos
News
ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with most common liver cancer
ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with...
ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer
ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer
ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low-risk, stage IIA colon cancer
ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low...
ASCO GI 2024: Dual immunotherapy treatment improves progression-free survival in certain patients with advanced colorectal cancer
ASCO GI 2024: Dual immunotherapy treatment improves progression-free survival in certain patients with advanced...
ASCO GI 2024: NETTER-2 Study shows promise in treating advanced gastroenteropancreatic neuroendocrine tumours
ASCO GI 2024: NETTER-2 Study shows promise in treating advanced gastroenteropancreatic neuroendocrine tumours

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation